SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Trading Update

1 Feb 2021 07:00

RNS Number : 9708M
James Halstead PLC
01 February 2021
 

 

 

1 February 2021

 

JAMES HALSTEAD PLC(the "Company")

Trading Update

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update ahead of its interim results for the half-year to 31 December 2020.

 

The backdrop to the trading period remained challenging with the resurgence of the Covid-19 virus and subsequent lockdown restrictions across most of the territories in which we trade. Nevertheless, the normal course of business has evolved and we continue to trade at normal levels through the various national lockdowns, but it has been hard work. The cost and availability of international freight towards the end of the period has also been a major issue - and there has been upward pressure on raw material costs.

 

In his AGM statement, on 12 November 2020, the Chairman, Mr. Anthony Wild, noted that trading to date had been encouraging in terms of turnover for the first four months of the current financial year with sales on a par with the levels of last year. This trend continued through November and December. Diverse projects using our flooring include a 10 cinema IMAX complex in Aruba, the AXA Insurance Towers in Casablanca, several modular hospital contracts in Argentina and the Big Brother house in Portugal.

 

Turnover has been solid and we believe this is a creditable performance against the prevailing market conditions. There was noticeable market share growth in the UK in November and December, due in part to "Brexit" concerns of customers about supply from European based competitors. Underlying margins were under pressure due to increased shipping costs both into the UK and on exports plus the difficulties of manufacturing during the six months owing to understandable manning problems. Notwithstanding this adversity, the Company expects to report pre-tax profit for the half-year in line with last year's record level.

 

Our balance sheet remains robust, with cash balances above our year end in June and the comparative for December 2019.

 

The interim results will be published on 31 March 2021.

 

Enquiries:

 

 

 

James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

 

 

 

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon /Nick Moore

 

 

 

Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

Dominic Morley/ Dan Norman

 

 

 

WH Ireland (Joint Broker)

Ben Thorne / Chris Hardie

 

Tel: 020 7220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKABKOBKDADB
Date   Source Headline
9th Apr 20265:32 pmRNSGrant of Options
8th Apr 20265:19 pmRNSHolding(s) in Company
31st Mar 20267:00 amRNSInterim Results
23rd Feb 20264:48 pmRNSPDMR Acquisition of Shares
30th Jan 20263:32 pmRNSShare Buyback - Replacement
30th Jan 20262:44 pmRNSShare Buyback
29th Jan 20267:00 amRNSTrading Update
8th Jan 20268:20 amRNSBlock Listing Six Monthly Return
5th Dec 20251:00 pmRNSResult of AGM
5th Dec 20257:00 amRNSChairman’s Statement to the Annual General Meeting
14th Nov 202512:12 pmRNSDirector/PDMR Shareholding
14th Nov 202512:11 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSPosting of Annual Report and Notice of AGM
1st Oct 20257:00 amRNSPreliminary Results
8th Sep 20257:00 amRNSNotice of Preliminary Results
29th Aug 20253:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSTrading Update
9th Apr 20255:32 pmRNSHolding(s) in Company
7th Apr 202512:25 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSInterim Results
6th Mar 202510:41 amRNSNotice of Interim Results - Replacement
6th Mar 20259:00 amRNSNotice of Inteirm Results
6th Mar 20257:00 amRNSNotice of Interim Results
31st Jan 20257:00 amRNSTrading Update and Notice of Results
27th Jan 20255:09 pmRNSDirector/PDMR Shareholding
6th Jan 20253:15 pmRNSBlock Listing Six Monthly Return
6th Dec 20242:09 pmRNSResults of AGM
6th Dec 20247:00 amRNSAGM Statement
18th Oct 20249:20 amRNSPosting of Annual R&A and Notice of AGM
1st Oct 20247:00 amRNSBoard Changes
1st Oct 20247:00 amRNSPreliminary Results
7th Aug 20248:05 amRNSBlock Listing Six Monthly Return
31st Jul 20247:00 amRNSTrading Update
15th Jul 20247:00 amRNSChange of Broker
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.